chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very mild pain at the injection site; Tendon pain; Low grade fever; Diarrhea; Very bad body and joint aches; Very bad body and joint aches; Tendons felt inflamed; Weak tendons; Few spots of sharp pains in my upper right chest; Felt a very strong full body -hot flushing effect; Had some sharp spots in my chest; My arm start to ache; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 24Apr2021 at 21:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, hypothyroidism, psoriasis and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), pimecrolimus (ELIDEL), minocycline hydrochloride (AMZEEQ), multivitamin (MANUFACTURER UNKNOWN) and ergocalciferol (VIT D); all medications for unknown indications from an unknown date and unknown if ongoing. The patient previously received morphine (MANUFACTURER UNKNOWN), etanercept (ENBREL), adalimumab (HUMIRA), sulfamethoxazole; trimethoprim (BACTRIM) and promethazine (PHENERGAN) and experienced drug allergy. On 24Apr2021, on the same day of vaccination, the patient experienced felt a very strong full body -hot flushing effect, had some sharp spots in chest that went away temporarily and arm start to ache (the night of the vaccine). On 25Apr2021, the patient experienced low grade fever, diarrhea, very bad body and joint aches, tendons felt inflamed and weak and few spots of sharp pains in upper right chest. On 26Apr2021, the third day after vaccination, the patient's condition was improved and she only had the arm pain, milder body/joint aches, and some tendon pain/weakness. On 27Apr2021, the fourth day after vaccination, the patient had only very mild pain at the injection site and more tendon pain/weakness. On 28Apr2021, day 5 after vaccination, she had mild tendon pain/weakness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt a very strong full body -hot flushing effect, very mild pain at the injection site, arm start to ache, low grade fever, diarrhea, very bad body and joint aches, tendons felt inflamed, few spots of sharp pains in my upper right chest and had some sharp spots in my chest was resolved on an unspecified date in Apr2021; while that of the event mild tendon pain/weakness was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
10 days after the vaccines the pt developed hives all over, low grade fever, throat sore. No medication was given.
7-10 days post injection, site of VARIVAX vaccine was red and firm, with residual bruising.
I received the influenza vaccination at my workplace. The same afternoon I began to have excruciating pain in my upper left arm at the injection site. This pain continued as a sharp pain as well as a soreness. I waited a few days for the soreness to clear up but when the pain got worse i visited my PCP. She prescribed hydrocodone for pain. She examined my arm and made a note of the bruising and swelling on my upper arm at the injection site. I took the hydrocodone as prescribed but had to add 1000mg of tylenol to relieve the pain. I was also using combination of heat and ice packs on the injection site. I revisited my PCP who could not prescribe any other pain medications and sent a referral to Doctor in orthopedics. There he examined me and ordered an MRI. The MRI showed extensive damage to my shoulder including a fracture.  I am currently in physical therapy.
No additional adverse effects reported.; one patient received one dose of improperly stored VARIVAX; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information about medical history, concurrent conditions, drug reactions/allergies and concomitant therapies was not provided.   On 10-MAR-2020, the patient was vaccinated with one dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # R020654, expiration date 18-JUL-2020; strength and vaccine dosage detail were not reported) subcutaneously for prophylaxis (product storage error). The sterile diluent (STERILE DILUENT) used to reconstitute the varicella virus vaccine live (oka/merck) (VARIVAX) was stored properly. Current temperature excursion was 5.7 Fahrenheit degrees for 18 minutes. Previous temperature excursion was -13.3 Celsius degrees for 18 minutes and -13.2 Celsius degrees for 18 minutes. No additional adverse effects reported. No product quality complaint (PQC) was involved in this case. Data logger was involved.
person devel muscular soreness & swelling lasting approx 4 days @ site of inject;
Booster show was administered by MA staff, realized the vaccine had expired.  Date vaccine was pulled from freezer was 11/24/21 with an expiration of 12/24/2021.  Vaccine was given on 12/28/2021 at 0830 AM, contacted Pfizer recommended re-vaccination of patient.   Patient waited the 15 minutes as advised after receiving the vaccine, no adverse effected noted during this time.  Patient and mother aware of expired vaccine.
tested positive for covid virus; This is a spontaneous report from a contactable consumer(patient). This consumer reported similar events for 2 patients. This is the 1st of 2 reports. The 66-year-old male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL9262), via an unspecified route of administration on 21Jan2021 15:00 at single dose for COVID-19 immunization.  Medical history included heart problems.  The patient's concomitant medications were not reported. His First Dose was on 21Jan2021 at about 3PM. Then on either 23Jan2021 or 24Jan2021 he was diagnosed positive for covid. To test him they did a nasal swab up the nose, and in 15 minutes they gave him the result. His Antibody infusion treatment (in other words receive donated antibodies to help fight the virus) was either 25Jan2021 or 26Jan2021. It did help him big time, he was feeling great. He was scheduled for his second dose on 11Feb2021. Outcome of event was unknown. Case was assessed as non-serious.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021145989 same reporter/drug, different patient.
Pharmacy providing vaccination services to a local medical clinic received notification (via email) two days after on-site flu clinic of a patient that presented with the following: severe arm pain, warm to touch, and very swollen at injection site
Left eye vision changes started about 2 weeks after flu shot.  Seen by optometry, got MRI head, lab work  and referred to ophthalmology.  On exam had 20/20 vision, peripheral visual field defect left eye on formal testing, retinal  foveal granularity, multiple peripheral white dots on retina, macular OCT with outer retina findings.  Three weeks after presentation, has developed photopsia but improving visual field and retina findings improving, resolved white dots but still foveal granularity.
5/24 fever 101, headache, joint pains, fatigue. 5/25 fever 100, joint pain. 5/27 fever 99, body aches, legs restless, fatigue, lump at 3 inch diameter at injection site. 5/31 lump resolving, no temp, body aches improved.
Overall Body Aches - Still occurring after 24 hours Weakness - Still occurring after 24 hours Tiredness - Still occurring after 24 hours Moderate pain in left arm - Still occurring after 24 hours  Took Advil the first night before bedtime.  Took more Advil on the morning of Dec 19th.
Extreme coughing with mucus build up. Left side of throat inflamed. Night sweats. Lowgrade fever reaching 100.7 second day of symptoms. First day temperature read 99.1.
Headache, head heaviness, blurred vision, and neck stiffness.  Unable to touch chin to chest.
her arm was swollen/ hand was also swollen; the joint in her shoulder felt like it was going to split off. It was extremely painful; her arm was swollen/ It was extremely painful; had been awake two nights unable to sleep due to pain; The pain was also creeping up her neck; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient (pregnant: no) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: En7200), via an unspecified route of administration in left arm on 16Feb2021 at 14:00 at single dose for covid-19 immunisation. The relevant medical history included latex allergy and bee allergy, all from an unspecified date. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), modafinil and unspecified thyroid medication. The patient stated that her arm was swollen and the joint in her shoulder felt like it was going to split off. It was extremely painful. Her hand was also swollen and she had to remove her rings. She had been awake two nights unable to sleep due to pain. The pain was also creeping up her neck. The events started on 18Feb2021 at 22:00. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment included steroids and pain killers sling for arm. No covid prior vaccination and no covid tested post vaccination. Therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.
On the 1st dose, my left eye drooped for 1 week; On the 1st dose, my left eye drooped for 1 week; then my face swelled up; After those symptoms went away I developed a swollen right lymph node; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 15:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included osteoarthritis right fingers, allergy to hazelnuts, mango and wine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included cetirizine hydrochloride (ZYRTEC), calcium (MANUFACTURER UNKNOWN), ascorbic acid/pyridoxal phosphate/tocopherol/retinol palmitate/docosahexaenoic acid/magnesium sulfate/cod-liver oil/eicosapentaenoic acid/mucin/ribes nigrum seed oil (HYDROEYE), ciclosporin (RESTASIS), glucose/potassium chloride/ sodium citrate acid (OASIS) and unspecified vitamins, all for unknown indications from unknown dates and unknown if ongoing. The patient previously took sulfamethoxazole (MANUFACTURER UNKNOWN) and cefalexin (CEPHALEXIN) and experienced allergy. On 17Apr2021, after the 1st dose, the patient's left eye drooped for 1 week; then her face swelled up; after those symptoms went away, on an unknown date in 2021, she developed a swollen right lymph node. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left eye drooped was resolved on 23Apr2021, while the clinical outcome of the event face swelled up was resolved on an unknown date in  2021. The clinical outcome of the event swollen right lymph node was not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 27Apr2021 at 08:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation.
felt a bit achy; rotten; Initial information was received on 27-Oct-2021 regarding an unsolicited valid non-serious case received from social media from consumer/non-health care professional under reference number - US-SA-SAC20211103000091.  This case involves a patient of (unknown demographics) who experienced felt a bit achy (pain) and rotten (unevaluable event), after receiving vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, concomitant medication(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious felt a bit achy (pain) and rotten (unevaluable event) (unknown latency) following the administration of INFLUENZA VACCINE.  No additional laboratory data was reported.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on batch number for this case.
1. Pain, swollen, and hard at the injection site. 2.vomitting 3. Headaches,  4. Lazy Right eye, and spasms
Headache, Myalgia, Chills, Fatigue Narrative:  Other Relevant History:
Patient had fever of 101 including alternating heat and chills, intense body aches, intense feelings of restlessless and emotional disturbance, including crying. Patient had very sore arm, all symptoms lasted roughly 3 days. Patient describes it as a horrible experience.
This case was reported by a healthcare professional and described the occurrence of swelling injection site in an 18-month-old female subject who was vaccinated with INFANRIX (GlaxoSmithKline).  Concurrent vaccinations given on 19 August 2008 included the 1st dose of VARIVAX (Merck);  unknown.  On 19 August 2008, the subject received the 4th dose of INFANRIX (.5 ml, unknown, left thigh).  On 21 August 2008, 2 days after vaccination with INFANRIX, the subject experienced swelling at the injection site and injection site redness.  The reporter indicated that medical attention was required at the physician's office.  The reporter stated that the INFANRIX vaccination series was neither discontinued, nor delayed.  At the time of reporting, the outcome of the events was unspecified.  Follow-up information was received on 12 September 2008 via a nurse, which conflicted with the initial information received on this subject.  The nurse indicated that the onset of the events occurred on 19 August 2008, which was the same say that the subject received the INFANRIX vaccination.  After an unspecified period of time, the events were resolved.  The healthcare professional considered the events to be related to vaccination with INFANRIX, but indicated that she did not consider the events to be serious.  The healthcare professional also indicated that the INFANRIX vaccination series was neither discontinued, nor delayed.
My tongue has become very dry since I received the first does of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DRY (My tongue has become very dry since I received the first does of the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TONGUE DRY (My tongue has become very dry since I received the first does of the vaccine). At the time of the report, TONGUE DRY (My tongue has become very dry since I received the first does of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported Treatment medication were not reported.
Painful bilateral axillary lymphadenopathy, CBC normal, ESR 43, CRP 7.1, improved quickly with a few days of high dose ibuprofen.
This case was reported by a pharmacist via call center representative and described the occurrence of upset stomach in a 79-year-old female patient who received SHINGRIX for prophylaxis. On 18th August 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In August 2018, several days after receiving SHINGRIX, the patient experienced upset stomach, feeling bad, extremities hot feeling of, injection site rash and erythema of extremities. On an unknown date, the outcome of the upset stomach, feeling bad, extremities hot feeling of, injection site rash and erythema of extremities were not recovered/not resolved. It was unknown if the reporter considered the upset stomach, feeling bad, extremities hot feeling of, injection site rash and erythema of extremities to be related to SHINGRIX. Additional details were reported as follows: A couple days later, the patient experienced an upset stomach as well as a localized rash on her arm around the injection site but it did extend (the rash was the size of a hand). This reaction went away but then about 2 weeks later, it came back. The healthcare professional stated that the patient feels like absolute garbage and her arm was red and hot and she had an upset stomach again. The healthcare professional didn't have lot or expiration date at this time. The patient's husband received the vaccine at the same time and he tolerated well without any issues.
18 hours after shot -- began to have a headache, then 5 hours later (at 5pm) my face felt hot. I rarely have headaches. I checked my temperature, but it was in the normal range (98.3 degrees)  I took Tylenol (2 pill), hydrated, ate dinner and slept. I felt ok the next day, just a little strange (hard to pinpoint issue ... but "off"). Took another 2-pill dose of Tylenol just in case.
Fatigue, headache, neck and back pain, muscle aches, chills, injection site pain and swelling, light headed, queezy, diarrhea.
Redness and swelling at R thigh after DTaP & varicella administered on 7/8/08.  Beginning to resolve.
Warm Red raised rash about fist size around the injection site.  Appeared one day after second dose. It is still 5 days out and it's still there, though it seems to be reseeding I did not treat it un any way
pt recvd vax & immed post vax exp redness & heat @ inj site;sx resolved;
A consumer reported that she received a dose of flu vaccine (manufacturer unknown) in 1995 and subsequently developed a runny nose for a week. No further information was available at the date of this report.
Headache, congestion, aches and pains, joints, loss of energy, Concentration, loss of testosterone,  chest pain, heart
Lacy non raised rash on body/extremities 4-5 hrs. after receiving HAV & HiB vaccine.  Rash resolved after few hours.  Mom just now informing us of rash.
No additional adverse effect reported.; patient received expired MMRII; This spontaneous report was received from a pharmacy technician, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, or allergies were not reported.  On 12-OCT-2020, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) injection (strength, dose, vaccination scheme, anatomical site of injection and route of administration were not reported; lot number R028382, expiration date reported as 03-OCT-2020, but upon internal validation it was established as 10-MAR-2020), as prophylaxis (expired product administered). No additional adverse effect reported.
While being supervised by an 11 yr old sibling child "stopped breathing" taken to neighbor, who reported pallor & hypotonia.  Appeared normal to ER physician by 20 min /p episode
Just under my left arm pit, i have a large lump come up on Saturday. Now it has gone down but is real sore.; Just under my left arm pit, i have a large lump come up on Saturday. Now it has gone down but is real sore.; This spontaneous case was reported by a nurse and describes the occurrence of AXILLARY PAIN (Just under my left arm pit, i have a large lump come up on Saturday. Now it has gone down but is real sore.) and AXILLARY MASS (Just under my left arm pit, i have a large lump come up on Saturday. Now it has gone down but is real sore.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced AXILLARY PAIN (Just under my left arm pit, i have a large lump come up on Saturday. Now it has gone down but is real sore.). On 22-Jan-2022, the patient experienced AXILLARY MASS (Just under my left arm pit, i have a large lump come up on Saturday. Now it has gone down but is real sore.). On 23-Jan-2022, AXILLARY MASS (Just under my left arm pit, i have a large lump come up on Saturday. Now it has gone down but is real sore.) had resolved. At the time of the report, AXILLARY PAIN (Just under my left arm pit, i have a large lump come up on Saturday. Now it has gone down but is real sore.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  It was reported that the patient took the vaccine on 20-Jan-2022 and just under their left arm pit, the patient was having large lump which come up on 22-Jan-2022 and now it had gone down but was real sore.  No treatment information was provided.
Legs went numb, vision was blurry, cold sweats, massive headache, couldn't standup, still experiencing chest pains, headache, shortness of breath, lungs feel full of fluid
Headache, Myalgia, Arthralgia, Reports headache, fatigue,chills,sweats, myalgias, arthralgias, and soreness at injection site 26 hours post-injection Narrative:  Reports headache, fatigue, chills, sweats, myalgias, arthralgias, and soreness at injection site 26 hours post-injection COVID-19 2nd Vaccine.
SORE ARM; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.